BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 28349378)

  • 1. Gastrointestinal Tract: a Promising Target for the Management of Hypertension.
    Xiong S; Li Q; Liu D; Zhu Z
    Curr Hypertens Rep; 2017 Apr; 19(4):31. PubMed ID: 28349378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Gastrointestinal Tract: an Initial Organ of Metabolic Hypertension?
    Zhu Z; Xiong S; Liu D
    Cell Physiol Biochem; 2016; 38(5):1681-94. PubMed ID: 27160520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension as a Metabolic Disorder and the Novel Role of the Gut.
    Tanaka M; Itoh H
    Curr Hypertens Rep; 2019 Jun; 21(8):63. PubMed ID: 31236708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance of Gastrointestinal Glucose Homeostasis by the Gut-Brain Axis.
    Chen X; Eslamfam S; Fang L; Qiao S; Ma X
    Curr Protein Pept Sci; 2017; 18(6):541-547. PubMed ID: 27356933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Gut Microbiota-Brain Axis by Probiotics, Prebiotics, and Diet.
    Liu X; Cao S; Zhang X
    J Agric Food Chem; 2015 Sep; 63(36):7885-95. PubMed ID: 26306709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mind-altering with the gut: Modulation of the gut-brain axis with probiotics.
    Kim N; Yun M; Oh YJ; Choi HJ
    J Microbiol; 2018 Mar; 56(3):172-182. PubMed ID: 29492874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of gut microbiota in association between GLP-1/GLP-1 receptor expression and gastrointestinal motility.
    Yang M; Fukui H; Eda H; Xu X; Kitayama Y; Hara K; Kodani M; Tomita T; Oshima T; Watari J; Miwa H
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G367-G373. PubMed ID: 28154011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of gut microbiota in the management of metabolic disorders: the prospects and challenges.
    Erejuwa OO; Sulaiman SA; Ab Wahab MS
    Int J Mol Sci; 2014 Mar; 15(3):4158-88. PubMed ID: 24608927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavonoids and the gastrointestinal tract: Local and systemic effects.
    Oteiza PI; Fraga CG; Mills DA; Taft DH
    Mol Aspects Med; 2018 Jun; 61():41-49. PubMed ID: 29317252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies to increase the efficacy of using gut microbiota for the modulation of obesity.
    Li J; Riaz Rajoka MS; Shao D; Jiang C; Jin M; Huang Q; Yang H; Shi J
    Obes Rev; 2017 Nov; 18(11):1260-1271. PubMed ID: 28742949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbe-host interactions: Influence of the gut microbiota on the enteric nervous system.
    Hyland NP; Cryan JF
    Dev Biol; 2016 Sep; 417(2):182-7. PubMed ID: 27343895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of the Gastrointestinal Microbiota in Visceral Pain.
    Rea K; O'Mahony SM; Dinan TG; Cryan JF
    Handb Exp Pharmacol; 2017; 239():269-287. PubMed ID: 28035535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of the gut in the metabolic syndrome: an overview.
    Fändriks L
    J Intern Med; 2017 Apr; 281(4):319-336. PubMed ID: 27991713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Perspectives on Antihypertensive Probiotics.
    Daliri EB; Lee BH; Oh DH
    Probiotics Antimicrob Proteins; 2017 Jun; 9(2):91-101. PubMed ID: 27900619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiota and the gut-brain axis.
    Bienenstock J; Kunze W; Forsythe P
    Nutr Rev; 2015 Aug; 73 Suppl 1():28-31. PubMed ID: 26175487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut hormones and gut microbiota: implications for kidney function and hypertension.
    Afsar B; Vaziri ND; Aslan G; Tarim K; Kanbay M
    J Am Soc Hypertens; 2016 Dec; 10(12):954-961. PubMed ID: 27865823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intersection of salt- and immune-mediated mechanisms of hypertension in the gut microbiome.
    Wyatt CM; Crowley SD
    Kidney Int; 2018 Mar; 93(3):532-534. PubMed ID: 29475542
    [No Abstract]   [Full Text] [Related]  

  • 19. Nutrition and the gut microbiome in the elderly.
    Salazar N; Valdés-Varela L; González S; Gueimonde M; de Los Reyes-Gavilán CG
    Gut Microbes; 2017 Mar; 8(2):82-97. PubMed ID: 27808595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota in hypertension.
    Jose PA; Raj D
    Curr Opin Nephrol Hypertens; 2015 Sep; 24(5):403-9. PubMed ID: 26125644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.